The important intracellular mechanisms of astrocyte growth are not well defined. Using an inhibitor of astrocyte proliferation, atrial natriuretic peptide (ANP), and the glial mitogen endothelin (ET-3), we sought a common pathway for growth regulation in these neural cells. In cultured fetal rat diencephalic astrocytes, ANP selectively and rapidly inhibited the Tis 8 immediate early gene and protein. After 4 h, ANP selectively inhibited the basic fibroblast growth factor (bFGF) gene and protein. ET-3 significantly stimulated both Tis 8 and bFGF mRNAs and protein, but also stimulated several other immediate early and growth factor/receptor genes. An antisense oligonucleotide to Tis 8 strongly prevented ET-stimulated thymidine incorporation, while the inhibitory action of ANP was enhanced. The Tis 8 antisense oligonucleotide also significantly reversed ET-stimulated bFGF transcription and enhanced the bFGF inhibition caused by ANP. In addition, an antisense oligonucleotide to bFGF significantly reversed the ET-stimulated thymidine incorporation and enhanced the ANP inhibition of DNA synthesis. The sequential modulation of Tis 8, followed by bFGF, provides a novel mechanism for both positive and negative regulation of astrocyte growth by endogenous neuro-
Introduction
Astrocytes in the central nervous system normally proliferate only during fetal life. Growth modulation at that time results, in part, from the action of peptide growth factors produced in various central nervous system cells, including glia. The response by astrocytes to extracellular growth stimuli includes the production and subsequent action of autocrine growth factors, produced through a cascade of poorly defined intracellular events. It is likely that immediate early gene activation and protein synthesis precedes and modulates the enhanced growth factor production in these cells (1) (2) (3) . Growth restraint could result from either the programmed cessation or the direct inhibition of the proliferative process. thesized in fetal and adult diencephalic neurons (4, 5) that binds to and acts as an anti-growth factor for astrocytes in vitro (6, 7) . Endothelin-3 (ET-3) is a vasoactive peptide synthesized in diencephalic neurons and glia (8, 9 ) that binds to astrocytes and neurons (10, 11) , and stimulates DNA synthesis in cultured glia ( 12, 13). Since ANP and ET modulate the proliferation ofdiencephalic astrocytes in culture, we reasoned that they might do so through a common mechanism involving the regulation of growth-related genes. The presence of a mature system ofneuropeptide synthesis, processing, and receptor expression for ANP and ET in vivo by gestational day 15 in the rat, implies that these two peptide neurotransmitters play a role in fetal brain development ( 14) .
Specific immediate early genes such as c-fos, c-myc, and c-jun have been implicated in the growth of various cells (15) (16) (17) . In the brain, treatment of astrocytes with the growth promoting phorbol esters strongly increases the expression of a series of immediate early genes. These TPA-inducible sequences or Tis genes ( 18) include two genes that are also inducible by neural growth factor (NGF), NGFIB (Tis 1), and NGFIA (Tis 8): The latter is the rat homologue of egr-1, (or krox 24 or zif 268) in other cell types (19) (20) (21) (22) . Tis 1 and Tis 8 are known transcription factors, binding via zinc fingers to DNA, and Tis 8 (egr-1), in particular, has been implicated in the regulation of cell growth (23) . It has not been established that these immediate early genes play a role in neural cell growth, and no target genes that are transcriptionally regulated by these proteins have been identified. Thus, in these studies, we attempted to deduce an intracellular pathway by which the endogenous neuropeptides ANP and ET regulate astrocyte proliferation, involving discrete immediate early and growth factor protein production.
Methods
Materials. cDNA probes for the TIS genes were kindly provided by Dr. Harvey Herschman, UCLA (24) , c-myc, c-jun, and EGF-R were from American Type Culture Collection (Rockville, MD) (25, 26) scribed (7, 30) . This approach yields a culture that is -95% glia by light microscopy after immunochemical staining for glial acidic fibrillary protein (30) . Cultures were also trypsinized and replated to yield first passage cultures that were 99% astrocytes, and data from primary or first passage astrocytes was identical. The cells were then plated in DME/F12 medium with 10% FBS. Studies using glia were typically carried out 10-14 d after plating. Astrocytes were incubated in the presence or absence of ANP, PMA, or ET-3, 10-7 M or 10-9 M, for various times up to 2 h (immediate early genes) or as long as 8-24 h (growth factor genes).
Si nuclease protection. The RNA from astrocytes cultured under the experimental conditions was extracted and the expression of the various genes under these conditions was determined after hybridization of labeled cRNA antisense probes with the experimental RNA. This was followed by SI nuclease digestion, separation of hybridized complexes by electrophoresis on denaturing polyacrylamide gel, and autoradiography, as previously described in detail (31, 32) . Sense probes produced no hybridization. The constructs of the various probes used were given in previous publications (see Methods) .
Nuclear run on assay. For nuclear run on, astrocytes were incubated in the presence or absence of ANP or ET, with or without an antisense construct for Tis 8 (see below) for 4 h. The cells were washed, then lysed in NP-40 lysis buffer. The nuclei were isolated after centrifugation, followed by freezing in glycerol storage buffer until use. As previously described for transcription studies (32) , the thawed nuclei (5 X 107 cells) were added to equal volume reaction buffer with 4 mM ATP, GTP, and CTP plus 10 y1 of [32P]UTP. After a 30-min incubation, the DNA was digested with DNase, followed by proteinase K digestion. The newly formed, 32P-labeled RNA was then purified and precipitated, then transferred onto HA filters (Whatman Inc., Clifton, NJ) and the RNA eluted. An aliquot of the RNA was counted and equal counts of labeled nuclear RNA from each experimental condition were hybridized with the cDNA for bFGF, spotted onto nitrocellulose filters (using a slot blot apparatus). Comparison was made using a cDNA for B-actin. After 36 h of hybridization, the filters were washed, RNase treated, and exposed to x-ray film for 1-3 d.
Antisense studies. For DNA synthesis experiments, astrocytes were incubated for 18 h with a 19-mer phosphorothionated antisense oligonucleotide directed to the coding region for TIS 8, commencing with the initiation ATG (5' CGG CCT TGG CCG CTG CCAT 3') (33), at various concentrations, before the addition ofET or ANP. As controls, a sense oligonucleotide (5' ATG GCA GCG GCC AAG GCC G 3') to Tis 8 or an antisense oligonucleotide for c-myc (5' AAC GTT GAG GGG CAT 3') was also used. We similarly incubated the cells with antisense (5' GGC AGC CAT GGC CCC 3') or sense (5' GGG GCC ATG GCT GCC 3') oligonucleotides to rat bFGF (21), 18 h before ANP or ET. The cells were then incubated with neuropeptides for 24 h.
At 20 h, the cells were pulsed with 0.1 tCi of [3H ] thymidine (specific activity 20 Ci/mmol) per well for 4 h, the cells were washed with PBS, incubated with 10% TCA, and harvested after overnight incubation in 0.5 ml of 0.2 N NaOH (7). TCA-precipitated counts were determined in a beta counter (Beckman Instruments, Fullerton, CA), and normalized for protein (Lowery). The same constructs were used for the effects on gene expression, determined by nuclear run-on and protection assay; preincubation of the astrocytes with the constructs for 18 h preceded neuropeptide addition.
Western blotting. Glia were incubated in the presence or absence of the neuropeptides for 90 or 120 min (Tis 8 (Fig. 2 A) . These experiments suggested that Tis 8, by itselfor in conjunction with other rapidly induced genes, might participate in the modulation of astrocyte growth by both mitogenic or growthinhibiting endogenous neuropeptides. Autologous growth factor expression. We then assessed which astrocyte-synthesized growth factors or receptors may be modulated by ANP and ET and, therefore, might serve as autologous growth promoting proteins for these cells. Several candidate proteins have been implicated in the growth of glia or glial-derived tumors, including PDGF-A, EGF-R, IGF-1, and bFGF (34) (35) (36) (37) (38) (39) (40) (41) ). We found that ANP inhibited the transcription of the bFGF gene by -45% after 4 h of incubation, (Fig. 3 A) . In our screening studies, ANP had no inhibitory effect on PDGF-A, EGF-R, or IGF-1. ET-3 caused a 2.0±0.2-fold increase in bFGF transcription (Fig. 3 A) , but also stimulated IGF-1 and EGF-R gene expression in astrocytes (data not shown). Taken together, the results pointed toward bFGF as the leading candidate for the endogenous growth factor that mediates these actions of ANP and ET, although other proteins, alone or in combination with bFGF, might contribute to this process.
Tis-8 effects on bFGF and DNA synthesis. To establish a definitive role for Tis 8 in first modulating bFGF gene expression and then astrocyte growth, we inhibited the production of the Tis 8 protein by using an antisense oligonucleotide (ASO) for this gene (33) . We first determined in preliminary experiments that inhibition of Tis 8 protein production in astrocytes by the ASO was dose related, including 80% at a concentration of I AM. So as not to obscure the effects of the neuropeptides (ANP or ET ), we chose a concentration of0.25 ,tM Tis 8 ASO, which inhibited the basal Tis 8 protein by 30±7% (Fig. 2 B) , based on three experiments combined. The Tis 8 ASO at this concentration nearly completely prevented the ET-3 stimulation ofTis 8 protein, which was 78±6% above control ( Fig. 2 B, lanes I vs 2 vs 3). In contrast, the control Tis 8 sense construct had no significant effect on ET-3-stimulated Tis 8 production (Fig. 2 B) . Fig. 4 . The stimulation of bFGF protein production by ET (70±4% increase compared to control cells) was completely inhibited by the Tis 8 ASO (Fig. 5 A) , supporting this specific mechanism of the ASO effect.
This ASO, in dose-related fashion, also significantly limited the ability of ET-3 to promote DNA synthesis (Fig. 6 A) (Figs. 4-6 promoting and bFGF-stimulating actions ofthis neuropeptide. In general, increased Tis 8 production may be an important early step during astrocyte growth, since other growth factors (EGF and the mitogenic phorbol esters) can also strongly stimulate the expression of this gene in cultured astrocytes (42) .
The effects of the ASO on ANP function were more complex. We postulated that the inhibitory effects ofANP on bFGF expression or astrocyte growth are dependent on first inhibiting Tis 8. Therefore, complete inhibition of Tis 8 protein production by the ASO might limit the subsequent action of ANP, while partial and additive inhibition could augment these actions of ANP. In fact, in our preliminary experiments, the Tis 8 ASO at 1 MM, significantly inhibited the proliferation of the astrocytes and the ability of ANP to act as an anti-growth factor for these cells. Therefore, to obscure the effects of ANP, we purposefully chose the concentrations of ASO used in this study on the basis ofthe pilot experiments described. We found that ANP inhibited bFGF mRNA levels by 50±2%, and the Tis 8 ASO, 0.25 MiM, augmented this action to 75±6% (Fig. 3 C,  lanes 1-3, and Fig. 4 ). ANP caused a 46±6% decrease in bFGF protein, which was augmented to 71±7% by the Tis 8 ASO (Fig. 5 A, lanes 4 and 7) . To support the idea that the ASO inhibits protein translation, we also showed that a higher concentration of the Tis 8 ASO, 0.5 MM, by itself causes a 55% decrease in unstimulated bFGF protein production (Fig. 5 A) .
The Tis 8 ASO also augmented the ANP inhibition of thymidine incorporation in astrocytes from 35 to 50%, but had little inhibitory effects by itself at 0.25 MM (Fig. 6 A) . The control sense oligonucleotide did not augment the action of ANP, and an antisense oligonucleotide to c-myc had little effect on this parameter. Since the ASO increased the growth inhibition induced by ANP, our findings imply that the de- were significantly attenuated by ANP (Fig. 6 A) Effects ofbFGFon DNA synthesis. To show that the modulation ofbFGF is critical for the regulation ofastrocyte proliferation by ANP or ET, we incubated the cells with an ASO to bFGF. The bFGF ASO by itself caused a 29±4% inhibition of the basal bFGF protein, based on three combined experiments (Fig. 5 B) . ET caused a 75±5% increase in bFGF protein production, and the bFGF ASO, but not the sense construct, nearly completely inhibited this stimulation (Fig. 5 B, lanes 2   vs 3 vs 5) . The bFGF ASO also reversed the ET-augmented thymidine incorporation by 80%, while having an insignificant effect itself (Fig. 6 B) . The inhibition of DNA synthesis was dose related, and was not seen with the corresponding sense probe. To better ensure that the inhibition of bFGF protein production was the singular mechanism by which this ASO acted, we found that adding exogenous bFGF to the cultured cells completely reversed the action of the bFGF ASO (Fig.  6 B) .
In contrast, this construct augmented the DNA-inhibitory action of ANP from 36 to 51%. The increased inhibition was dose related, and was reversed by the addition of exogenous bFGF (Fig. 6 B) . These results indicate that bFGF is likely to mediate the growth modulating actions of the two neuropeptides. To provide additional support for the idea that ANP and ET work through a similar mechanism, we found that ANP inhibited 81±5% of the ET-stimulated DNA synthesis (Fig.  6A) .
Glioma. We also examined the expression and regulation of Tis 8 by ANP and ET in a rat glioma cell line (C6). Both C6 and human astrocytoma cells are well characterized as having both ANP and ET cell surface receptors (43, 44) , findings that we confirmed. We found that basal C6 cells demonstrated a strong expression ofthe Tis 8 gene (Fig. 7) , which was as much as eightfold greater than the expression in comparable amounts of RNA from basal cultured diencephalic astrocytes. Importantly, both ANP and ET-3 failed to inhibit or stimulate, respectively, the expression of this gene. with H-ras is shown below. There was no effect of either ANP or ET on Tis 8 expression in these cells.
Discussion
Our results indicate that both growth stimulating and inhibiting endogenous neuropeptides modulate DNA synthesis and the proliferation of cultured diencephalic astrocytes (7, 12, 13) via a common pathway. ET stimulates the immediate early gene, Tis 8, which then leads to the increased transcription and augmented protein production of bFGF. The stimulation of Tis 8 is necessary for these actions of ET on both bFGF and increased DNA synthesis, since an ASO to Tis 8 reverses these actions: a corresponding sense oligonucleotide for Tis 8 has little effect. This is the first identification, to our knowledge, of a specific immediate early gene/transcription factor that stimulates bFGF production. The importance of Tis 8 is highlighted by the fact that an ASO for c-myc had no effect on ET-stimulated bFGF or thymidine incorporation, even though ET stimulates c-myc expression in the astrocytes.
It has been shown that ET is mitogenic for the vascular smooth muscle cell (45) , and stimulates c-fos and c-myc in these and other cells (46 (48) . One of the objections to postulating that bFGF is an important autologous growth factor for glia is that the protein lacks the traditional leader sequence necessary for secretion, and subsequent binding to cell surface FGF receptors expressed on astrocytes (49) . However, it may not be necessary for bFGF to be secreted. Acidic and basic FGF each contain a sequence that allows the protein to enter the nucleus ofthe cell. Basic FGF has been found in the nucleus ofastrocytes or endothelial cells, where it increases the production of specific ribosomal protein and may contribute to growth ( 50, 51 ), potentially through stimulating the production or activation of pro-teins that are crucial for induction of the cell cycle. Early studies have also called into question whether bFGF is found in the in vivo brain, as opposed to its abundant presence in cultured astrocytes. More recent findings in brain slices clearly indicate that bFGF is found throughout the central nervous system, localized mainly to astrocytes (52) . Thus, the modulation of in vivo astrocyte growth by endogenous proteins could occur via this pathway.
The stimulation ofbFGF transcription by ET appears to be mediated through Tis 8. This might occur as a result of the Tis 8 protein binding to the promoter and transcriptionally transactivating the bFGF gene. However, the canonical egr-1 DNAbinding sequence (CGCCCCCGC) (23) is not present in the bFGF promoter. There is a binding site for the zinc finger protein, sp-l (CCGCCC) (53) in the bFGF promoter, and this sequence might bind egr-l, since there is a 5-nucleotide, G-Crich overlap ofthese two sequences. Further detailed analysis is necessary to precisely understand the mechanism of bFGF transcriptional stimulation by ET, as mediated through Tis 8.
Tis 8 and bFGF appear to mediate the growth inhibitory actions of ANP. ANP selectively inhibited both basal or mitogen-stimulated Tis 8. This probably led to the inhibition of bFGF gene expression and protein production, and to the subsequent decrease in DNA synthesis. These effects were augmented by the ASO to Tis 8, but not c-myc. Our findings describe ANP as the first identified endogenous protein that negatively modulates Tis 8 production and, thus, provides a model to understand the mechanism of inhibition of this important immediate early gene and protein. As mentioned, we also found that an ASO to bFGF augmented ANP inhibition of DNA synthesis.
ANP also inhibited the augmented thymidine incorporation caused by the astrocyte mitogens, PMA, or endothelin. Since both these substances were shown to stimulate Tis 
